FL118, a novel survivin inhibitor, wins the battle against drug-resistant and metastatic lung cancers through inhibition of cancer stem cell-like properties.

导出 OA

翻译打印收藏纠错

作者： Jin,Wang ^[1] ; Zhantao,Liu ^[2] ; Dandan,Zhang ^[2] ; Ranran,Liu ^[2] ; Qian,Lin ^[2] ; Jia,Liu ^[2] ; Zhihong,Yang ^[2] ; Qingxia,Ma ^[2] ; Dantong,Sun ^[1] ; Xin,Zhou ^[1] ; Guohui,Jiang ^[2]

作者单位： School of Basic Medicine, Qingdao UniversityQingdao 266021, China. ^[1] School of Pharmacy, Qingdao UniversityQingdao 266021, China. ^[2]

关键词 FL118 antitumor activity cancer stem cells drug resistance metastasis survivin

PMID 28861158

发布时间 2020-09-29

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览10

American journal of translational research

2017年9卷8期

3676-3686页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

FL118, a novel survivin inhibitor, wins the battle against drug-resistant and metastatic lung cancers through inhibition of cancer stem cell-like properties.

American journal of translational research

相似文献

American journal of translational research

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

FL118, a novel survivin inhibitor, wins the battle against drug-resistant and metastatic lung cancers through inhibition of cancer stem cell-like properties.

American journal of translational research

相似文献

American journal of translational research

相关期刊

检索历史清除